Heart Disease News and Research

Latest Heart Disease News and Research

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Santaris Pharma A/S, a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced that its long term partner, Shire has extended the existing partnership in the rare genetic disease space.

23 Aug 2013

Research findings lay foundation for regenerating damaged heart muscle

In the aftermath of a heart attack, cells within the region most affected shut down. They stop beating. And they become entombed in scar tissue. But now, scientists at the Gladstone Institutes have demonstrated that this damage need not be permanent-by finding a way to transform the class of cells that form human scar tissue into those that closely resemble beating heart cells.

23 Aug 2013

Challenges of studying health and mortality risks of obesity

Researchers from the Perelman School of Medicine point out that the body mass index, based on the weight and height, is not an accurate measure of body fat content and does not account for critical factors that contribute to health or mortality, such as fat distribution, proportion of muscle to fat, and the sex and racial differences in body composition.

23 Aug 2013

Healthy and obese kids who participated in lifestyle modification program show improved heart health

A UCLA School of Nursing study has found that both healthy-weight and obese children who participated in an intensive lifestyle modification program significantly improved their metabolic and cardiovascular health despite little weight loss.

23 Aug 2013

New technique may convert cells from heart disease patients into heart muscle cells

Researchers have developed a new technique that might one day be used to convert cells from heart disease patients into heart muscle cells that could act as a personalized treatment for their condition.

23 Aug 2013

Age, sex and race may predict risk factor reduction in patients with coronary heart disease

Risk factor modification efforts could help reduce the chance of another heart attack and death among the more than 15 million Americans with coronary heart disease. Yet some patients-especially women and minorities-leave the hospital with poorly managed risk factors.

23 Aug 2013

Structured exercise can improve heart function in patients with kidney disease

A structured exercise and lifestyle program can improve fitness, body composition, and heart function in patients with kidney disease, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN).

23 Aug 2013

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

Variants in a particular gene are linked with an increased risk for kidney complications in patients with lupus, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings could lead to better treatments to protect the kidney health of patients with the disease.

23 Aug 2013

Scientists develop new way to detect threatening nanoparticles in food

Over the last few years, the use of nanomaterials for water treatment, food packaging, pesticides, cosmetics and other industries has increased. For example, farmers have used silver nanoparticles as a pesticide because of their capability to suppress the growth of harmful organisms. However, a growing concern is that these particles could pose a potential health risk to humans and the environment.

23 Aug 2013

Study confirms exposure to arsenic in drinking water can impair lung function

A new study confirms that exposure to low to moderate amounts of arsenic in drinking water can impair lung function. Doses of about 120 parts per billion of arsenic in well water-about 12 times the dose generally considered safe-produced lung damage comparable to decades of smoking tobacco. Smoking, especially by males, made arsenic-related damage even worse.

23 Aug 2013

Takeda Launches New Subsidiary In Peru

...

22 Aug 2013

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain and the development of its immune modulating drug candidate WF10 today announced that its U.S. licensee for PENNSAID (diclofenac sodium topical solution) 1.5% w/w and PENNSAID 2% (diclofenac sodium topical solution) 2% w/w, Mallinckrodt has advised that the U.S. Food and Drug Administration has accepted for filing and review the New Drug Application for PENNSAID 2% submitted by Mallinckrodt on August 7, 2013.

22 Aug 2013

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

In an examination comparing the effects of two drugs on blood pressure, pulse, heart rate and cardiac output in women having elective delivery by cesarean section, an old assumption that uterine blood is redistributed into the maternal circulation after delivery was challenged, according to a study in the September issue of Anesthesiology.

22 Aug 2013

Virtual 3-D heart model analyzes defibrillator placement in children born with heart defects

The small size and abnormal anatomy of children born with heart defects often force doctors to place lifesaving defibrillators entirely outside the heart, rather than partly inside — a less-than-ideal solution to dangerous heart rhythms that involves a degree of guesstimating and can compromise therapy.

22 Aug 2013

Researchers examine important risk factors in increasing chances of heart attack

Researchers in India have carried out a data mining exercise to determine which are the most important risk factors in increasing the chances of an individual suffering a heart attack.

22 Aug 2013

University of Adelaide wins $2.24M to establish new national Center of Research Excellence

The University of Adelaide has won US$2.24 million to establish a new national Center of Research Excellence, in partnership with the South Australian Health and Medical Research Institute (SAHMRI), the National Aboriginal Community Controlled Health Organization (NACCHO) and the University of Wollongong.

22 Aug 2013

People exposed to hot environments may develop Malignant hyperthermia

There is mounting evidence that some people who are susceptible to Malignant hyperthermia (MH) will develop MH when exposed to hot environments or with exercise.

22 Aug 2013

Researchers report overall increase in use of tPA to dissolve clots blocking arteries

Use of the "clot-busting" drug tissue plasminogen activator to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011.

22 Aug 2013

Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA

Our research uses mathematical modelling to quantify calorie intake as children grow at a healthy rate as well as when they develop obesity. We showed that the development of childhood obesity required a much greater increase in calories than previously thought since prior estimates did not properly account for metabolic changes as children grow.

21 Aug 2013

Hypertension researcher receives Distinguished Scientist title from AHA

Kenneth Bernstein, MD, a Cedars-Sinai pathologist and scientific researcher known for expanding the understanding of a collection of proteins important in controlling blood pressure as well as heart and renal diseases, has been named a 2013 Distinguished Scientist by the American Heart Association.

21 Aug 2013

Heart Disease News and Research

Latest Heart Disease News and Research

Shire extends existing partnership with Santaris Pharma in rare genetic disease space

Research findings lay foundation for regenerating damaged heart muscle

Challenges of studying health and mortality risks of obesity

Healthy and obese kids who participated in lifestyle modification program show improved heart health

New technique may convert cells from heart disease patients into heart muscle cells

Age, sex and race may predict risk factor reduction in patients with coronary heart disease

Structured exercise can improve heart function in patients with kidney disease

Study: Gene variants linked with increased risk for kidney complications in patients with lupus

Scientists develop new way to detect threatening nanoparticles in food

Study confirms exposure to arsenic in drinking water can impair lung function

Takeda Launches New Subsidiary In Peru

Nuvo: FDA accepts to review New Drug Application for PENNSAID 2%

Assumption that uterine blood redistributed into maternal circulation after delivery challenged

Virtual 3-D heart model analyzes defibrillator placement in children born with heart defects

Researchers examine important risk factors in increasing chances of heart attack

University of Adelaide wins $2.24M to establish new national Center of Research Excellence

People exposed to hot environments may develop Malignant hyperthermia

Researchers report overall increase in use of tPA to dissolve clots blocking arteries

Childhood obesity: an interview with Dr. Kevin Hall, NIDDK, National Institutes of Health, Bethesda, USA

Hypertension researcher receives Distinguished Scientist title from AHA

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Heart Disease News and Research

Latest Heart Disease News and Research

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in